Company intelligence / Profile preview

Chemopharm

Ownership: Private
Development stage: Commercial

Overview

Chemopharm provides products and services to over 4,000 customers in Southeast Asia—including hospitals, laboratories, research facilities—covering scientific research/academic segments as well as clinical diagnostics and analytical testing. The company represents more than 50 prestigious principals in the medical device/equipment market[8][10].

Industry: Consulting

Partnerships

Partnerships with over 50 global principals/suppliers of laboratory equipment and medical devices

Beyond the preview

Go deeper on Chemopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemopharm.

Explore the full profile